 Sangamo Therapeutics, Inc. NASDAQ:SGMO Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief Executive Officer Nathalie Dubois-Stringfellow - Chief Development Officer Jason Fontenot - Chief Scientific Officer Prathyusha Duraibabu - Chief Financial Officer Bettina Cockroft - Chief Medical Officer Mark McClung - Chief Operating Officer Conference Call Participants Gena Wang - Barclays Yanan Zhu - Wells Fargo Ritu Baral - Cowen Company Operator Good day, and thank you for standing by. Welcome to the Sangamo Therapeutics Third Quarter Earnings Call. 